Cyclopropanes - PDFSEARCH.IO - Document Search Engine

Cyclopropanes
Results: 865

#	Item
241	AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 431 NEVIRAPINE (Viramune) WHAT IS NEVIRAPINE? Add to Reading List Source URL: aidsinfonet.org Language: English - Date: 2014-04-16 14:34:58 Non-nucleoside reverse transcriptase inhibitors Cyclopropanes Biology Lactams Nevirapine Pyridines Antiretroviral drug Reverse-transcriptase inhibitor HIV Chemistry Organic chemistry HIV/AIDS
242	I am HIV infected and pregnant. Is it safe to use anti-HIV medications during my pregnancy? Women infected with HIV can safely use anti-HIV medications during pregnancy to protect their health and to prevent transmitting Add to Reading List Source URL: www.1test2lives.org Language: English - Date: 2012-11-09 15:40:14 Medicine Organofluorides Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Bristol-Myers Squibb Antiretroviral drug HIV Reverse-transcriptase inhibitor AIDS Chemistry Organic chemistry HIV/AIDS
243	Central Line–Associated Bloodstream Infections in Intensive Care Units in Québec, Surveillance Results 2012–2013 Healthcare-Associated Infections Provincial Surveillance Program Volume 1 NO 5 \| December 2013 Add to Reading List Source URL: www.inspq.qc.ca Language: English - Date: 2014-08-21 08:28:41 Piperazines Cyclopropanes Infectious diseases Intensive care medicine Intensive-care unit Gram-negative bacteria Intensive-care medicine Pefloxacin Ciprofloxacin Medicine Health Chemistry
244	Anti-Inflammatory Drugs for Post-operative Indications Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) February 27, 2012 Renata Albrecht, MD Add to Reading List Source URL: www.fda.gov Language: English ISTA Pharmaceuticals Ophthalmology Non-steroidal anti-inflammatory drugs Piperazines Cyclopropanes Medicine Dermatologic and Ophthalmic Drugs Advisory Committee Food and Drug Administration
245	PDF Document Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-04-21 16:03:04 Purines Cyclopropanes Organofluorides Bristol-Myers Squibb Antivirals Abacavir Lamivudine Fixed-dose combination Reverse-transcriptase inhibitor Chemistry Organic chemistry Pharmacology
246	--------------------- DOSAGE FORMS AND STRENGTHS --------------------Tablets: 600 mg of abacavir, 50 mg of dolutegravir, and 300 mg of lamivudine. (3) HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include Add to Reading List Source URL: www.gsksource.com Language: English - Date: 2014-12-03 00:15:28 Chemistry Organic chemistry Fixed dose combination Pharmacology Organofluorides Purines Abacavir Cyclopropanes
247	AIDS InfoNet www.aidsinfonet.org Fact Sheet Number 431 Add to Reading List Source URL: aidsinfonet.org Language: English - Date: 2014-04-16 14:34:58 HIV/AIDS Cyclopropanes Biology Lactams Nevirapine Pyridines Antiretroviral drug Reverse-transcriptase inhibitor HIV Chemistry Organic chemistry Non-nucleoside reverse transcriptase inhibitors
248	[removed]PRESCRIBING INFORMATION Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:51:12 Purines Organofluorides Cyclopropanes Fixed dose combination Abacavir Antivirals Lamivudine Fixed-dose combination Antiretroviral drug Chemistry Organic chemistry Pharmacology
249	AIDS InfoNet[removed]www.aidsinfonet.org Fact Sheet Number 415 LAMIVUDINE (Epivir) Add to Reading List Source URL: www.aidsinfonet.org Language: English - Date: 2014-02-05 12:30:58 Organofluorides Organic chemistry Purines Gilead Sciences Lamivudine Cyclopropanes Abacavir Antiretroviral drug Reverse-transcriptase inhibitor Chemistry Fixed dose combination Pharmacology
250	AIDS InfoNet[removed]www.aidsinfonet.org Fact Sheet Number 432 EFAVIRENZ (Sustiva, Stocrin) WHAT IS EFAVIRENZ? Add to Reading List Source URL: aidsinfonet.org Language: English - Date: 2014-05-16 11:58:28 Non-nucleoside reverse transcriptase inhibitors Medicine HIV/AIDS Cyclopropanes Organofluorides Efavirenz Antiretroviral drug Reverse-transcriptase inhibitor Emtricitabine/tenofovir/efavirenz Chemistry Organic chemistry Bristol-Myers Squibb

UPDATE